34 results on '"Driessen, Maurice T."'
Search Results
2. A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy
3. Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
4. Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
5. A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
6. Comment on: Gao B, Lu Q, Wan R, Wang Z, Yang Y, Chen Z, Wang Z. “Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials”. Naunyn Schmiedebergs Arch Pharmacol. 2021 Apr;394(4):819–828. Epublished November 2020
7. Assessment of rituximab-abbs, a biosimilar, and rituximab outcomes in patients with CLL or NHL: A real-world UK study
8. Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study
9. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD
10. Reductions in Migraine-related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: Results of a Long-term US Claims Database Analysis (P12-2.002)
11. Reductions in Acute Medication Use for Patients with Migraine Initiating Fremanezumab: Results of a Long-term US Claims Database Analysis (P16-2.005)
12. Additional file 1 of Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
13. Additional file 1 of Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
14. Additional file 3 of Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
15. Additional file 2 of Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
16. The effectiveness of participatory ergonomics to prevent low-back and neck pain — results of a cluster randomized controlled trial
17. Participatory ergonomics to reduce exposure to psychosocial and physical risk factors for low back pain and neck pain: results of a cluster randomised controlled trial
18. Authors' response: RCTs of ergonomic interventions
19. The effectiveness of physical and organisational ergonomic interventions on low back pain and neck pain: a systematic review
20. Real-world patient characteristics, treatment patterns and costs in relapsing multiple sclerosis patients treated with glatiramer acetate, dimethyl fumarate or teriflunomide in Germany
21. Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson’s Disease in The Netherlands
22. Real-world overall response rate and other outcomes related to originator and biosimilar rituximabin patients with chronic lymphocytic leukemia or non-Hodgkin’s lymphoma in the United Kingdom.
23. Clinical Outcomes and Health-Care Resource Use Associated With Reslizumab Treatment in Adults With Severe Eosinophilic Asthma in Real-World Practice
24. Cost-effectiveness of conservative treatments for neck pain: a systematic review on economic evaluations
25. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD
26. Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study
27. Process evaluation of a participatory ergonomics programme to prevent low back pain and neck pain among workers
28. What are possible barriers and facilitators to implementation of a Participatory Ergonomics programme?
29. Stay@Work: Participatory Ergonomics to prevent low back and neck pain among workers: design of a randomised controlled trial to evaluate the (cost-)effectiveness
30. Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
31. Workplace interventions for preventing work disability
32. Stay@Work: Participatory Ergonomics to prevent low back and neck pain among workers: design of a randomised controlled trial to evaluate the (cost-)effectiveness
33. Workplace interventions for preventing work disability
34. Real-world patient characteristics, treatment patterns and costs in relapsing multiple sclerosis patients treated with glatiramer acetate, dimethyl fumarate or teriflunomide in Germany.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.